Literature DB >> 9528902

A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection.

T Höhler1, A Kruger, G Gerken, P M Schneider, K H Meyer zum Büschenefelde, C Rittner.   

Abstract

Cytokines such as TNF-alpha and interferon gamma (IFN-gamma) are important for the elimination of infected hepatocytes during acute hepatitis B virus (HBV) infection. Two G versus A transitions in the TNF-alpha promoter region at positions -308 and -238 possibly influence TNF-alpha expression. We investigated these TNF-alpha polymorphisms in 71 patients with chronic HBV infection, in 32 subjects that had spontaneously recovered from acute HBV infection, and in 99 healthy controls. The -238 A promoter variant was present in 18 (25%) of 71 patients with chronic HBV infection compared with two (6%) of 32 subjects with acute infection (P<0.04), and seven (7%) of 99 controls (P<0.003). By contrast, the prevalence of the variant at position -308 was similar in all investigated groups. The observed differences could not be explained by linkage disequilibrium to HLA-B or -DRB1* alleles. These findings suggest an association between the TNF-alpha promoter polymorphism at position -238 and the development of chronic HBV infection. This promoter variant appears to be linked to defective viral clearance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528902      PMCID: PMC1904884          DOI: 10.1046/j.1365-2249.1998.00534.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Performing the exact test of Hardy-Weinberg proportion for multiple alleles.

Authors:  S W Guo; E A Thompson
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

2.  A polymorphic variation in a putative regulation box of the TNFA promoter region.

Authors:  S D'Alfonso; P M Richiardi
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene.

Authors:  M E Goldsmith; M J Madden; C S Morrow; K H Cowan
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

4.  Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.

Authors:  L G Guidotti; P Borrow; M V Hobbs; B Matzke; I Gresser; M B Oldstone; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

6.  Common west African HLA antigens are associated with protection from severe malaria.

Authors:  A V Hill; C E Allsopp; D Kwiatkowski; N M Anstey; P Twumasi; P A Rowe; S Bennett; D Brewster; A J McMichael; B M Greenwood
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

7.  Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study.

Authors:  I S Sheen; Y F Liaw; D Y Lin; C M Chu
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

8.  Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon.

Authors:  G L Davis; J H Hoofnagle; J G Waggoner
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

9.  Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis.

Authors:  R González-Amaro; C García-Monzón; L García-Buey; R Moreno-Otero; J L Alonso; E Yagüe; J P Pivel; M López-Cabrera; E Fernández-Ruiz; F Sánchez-Madrid
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

10.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors:  A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  51 in total

1.  Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population.

Authors:  Xiuchan Guo; Yong Zhang; Ji Li; Jingchen Ma; Zuli Wei; Wenjie Tan; Stephen J O'Brien
Journal:  Hepatology       Date:  2011-01-04       Impact factor: 17.425

2.  TNF-alpha promoter polymorphism in relation to TNF-alpha production and clinical status in cystic fibrosis.

Authors:  Sabina Schmitt-Grohé; Frank Stüber; Malte Book; Joachim Bargon; Thomas O Wagner; Christian Naujoks; Ralf Schubert; Michael J Lentze; Stefan Zielen
Journal:  Lung       Date:  2006 Mar-Apr       Impact factor: 2.584

3.  Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.

Authors:  Siwei Nie; Markus Cornberg; Liisa K Selin
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

4.  Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Authors:  Zhi-Tao Yang; Xin-Xin Zhang; Xiao-Fei Kong; Dong-Hua Zhang; Shen-Ying Zhang; Jie-Hong Jiang; Qi-Ming Gong; Gen-Di Jin; Zhi-Meng Lu
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 5.  Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Authors:  Francesca De Nard; Monica Todoerti; Vittorio Grosso; Sara Monti; Silvia Breda; Silvia Rossi; Carlomaurizio Montecucco; Roberto Caporali
Journal:  World J Hepatol       Date:  2015-03-27

Review 6.  Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection.

Authors:  Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

7.  Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians.

Authors:  William Abbott; Edward Gane; Ingrid Winship; Stephen Munn; Colin Tukuitonga
Journal:  Immunogenetics       Date:  2007-01-09       Impact factor: 2.846

8.  Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Authors:  Chloe L Thio; Jacquie Astemborski; Arman Bashirova; Timothy Mosbruger; Spencer Greer; Mallory D Witt; James J Goedert; Margaret Hilgartner; Audrey Majeske; Stephen J O'Brien; David L Thomas; Mary Carrington
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B.

Authors:  Yong Kwang Park; Jung Min Lee; Do Young Kim; Hye Young Chang; Ja Kyung Kim; Chun Kyon Lee; Jun Yong Park; Sang Hoon Ahn; Kwan Sik Lee; Kwang Hyub Han
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

Review 10.  A rationalized approach to the treatment of patients infected with hepatitis B.

Authors:  Natravis R Cox; Keyur Patel; Hans L Tillmann
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.